• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LPA 基因 kringle IV-2 重复拷贝数低与脂蛋白(a)浓度升高相关,是汉族人群冠心病的独立危险因素。

Low LPA gene kringle IV-2 repeat copy number association with elevated lipoprotein (a) concentration as an independent risk factor of coronary atherosclerotic heart disease in the Chinese Han population.

机构信息

Department of Clinical Laboratory, Shanghai East Hospital, Tongji University School of Medicine, No. 150, Jimo Road, Shanghai, 200120, People's Republic of China.

出版信息

Lipids Health Dis. 2018 May 10;17(1):111. doi: 10.1186/s12944-018-0753-1.

DOI:10.1186/s12944-018-0753-1
PMID:29747697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5946444/
Abstract

BACKGROUND

Lipoprotein (a) [Lp(a)], which is genetically determined by the LPA gene kringle IV type 2 (KIV-2) repeat copy number, has previously been reported in different populations. However, it is uncertain if the same occurs in the Chinese Han population. This study explored the correlation of Lp(a) mass or particle concentration with KIV-2 repeat copy number and application for coronary atherosclerotic heart disease (CAHD) risk assessment.

METHODS

A cross-sectional study including 884 subjects was conducted. The Lp(a) level and routine risk factors of CAHD were compared. The KIV-2 copy number distribution, relationship with Lp(a), and assessment for CAHD risk were explored.

RESULTS

The mean of Lp(a) mass or particle concentration in the CAHD group was higher than that in the non-CAHD group, while the KIV-2 copy number in the CAHD group was lower. Lp(a) had auxiliary values in gauging the type of plaque and was significantly higher in the soft-plaque group than that in the other two groups (200 mg/L [21.5 nmol/L], 166 mg/L [18.6 nmol/L], 149 mg/L [17.1 nmol/L], respectively, P < 0.05). Kappa test indicated divergence for the same individual using two Lp(a) concentrations (kappa value was 0.536 [< 0.75]). Elevated Lp(a) was an independent CAHD risk factor, whatever mass or particle concentration, and large KIV-2 copy number was a protective factor.

CONCLUSION

Lp(a) level and small KIV-2 copy number are risk factors for CAHD in the Chinese Han population; furthermore, elevated Lp(a) may gauge the type of coronary plaque.

摘要

背景

脂蛋白 (a) [Lp(a)] 由 LPA 基因kringle IV 型 2 (KIV-2) 重复拷贝数决定,先前在不同人群中已有报道。然而,中国人是否也存在这种情况尚不确定。本研究探讨了 Lp(a)质量或颗粒浓度与 KIV-2 重复拷贝数的相关性及其在冠状动脉粥样硬化性心脏病 (CAHD) 风险评估中的应用。

方法

进行了一项包括 884 例受试者的横断面研究。比较了 CAHD 组和非 CAHD 组的 Lp(a)水平和常规 CAHD 危险因素。探讨了 KIV-2 拷贝数分布、与 Lp(a)的关系以及 CAHD 风险评估。

结果

CAHD 组的 Lp(a)质量或颗粒浓度均值高于非 CAHD 组,而 CAHD 组的 KIV-2 拷贝数则较低。Lp(a)有助于评估斑块类型,软斑块组明显高于其他两组(200mg/L[21.5nmol/L]、166mg/L[18.6nmol/L]、149mg/L[17.1nmol/L],P<0.05)。Kappa 检验表明,使用两种 Lp(a)浓度对同一个体的判断存在分歧(kappa 值为 0.536 [<0.75])。升高的 Lp(a)是 CAHD 的独立危险因素,无论质量或颗粒浓度如何,大的 KIV-2 拷贝数都是保护因素。

结论

中国人中 Lp(a)水平低和 KIV-2 拷贝数小是 CAHD 的危险因素;此外,升高的 Lp(a)可能有助于评估冠状动脉斑块的类型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/5946444/da3bc416a55c/12944_2018_753_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/5946444/d6de0759bbe1/12944_2018_753_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/5946444/50039914d90c/12944_2018_753_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/5946444/a093bd7da0c4/12944_2018_753_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/5946444/da3bc416a55c/12944_2018_753_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/5946444/d6de0759bbe1/12944_2018_753_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/5946444/50039914d90c/12944_2018_753_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/5946444/a093bd7da0c4/12944_2018_753_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c375/5946444/da3bc416a55c/12944_2018_753_Fig4_HTML.jpg

相似文献

1
Low LPA gene kringle IV-2 repeat copy number association with elevated lipoprotein (a) concentration as an independent risk factor of coronary atherosclerotic heart disease in the Chinese Han population.LPA 基因 kringle IV-2 重复拷贝数低与脂蛋白(a)浓度升高相关,是汉族人群冠心病的独立危险因素。
Lipids Health Dis. 2018 May 10;17(1):111. doi: 10.1186/s12944-018-0753-1.
2
Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.脂蛋白(a)和载脂蛋白(a)同工型大小:与冠状动脉疾病的血管造影程度和严重程度以及颈动脉斑块的关系。
Atherosclerosis. 2018 Aug;275:232-238. doi: 10.1016/j.atherosclerosis.2018.06.863. Epub 2018 Jun 18.
3
The correlation between lipoprotein(a) and coronary atherosclerotic lesion is stronger than LDL-C, when LDL-C is less than 104 mg/dL.当 LDL-C 低于 104mg/dL 时,脂蛋白(a)与冠状动脉粥样硬化病变的相关性强于 LDL-C。
BMC Cardiovasc Disord. 2021 Jan 19;21(1):41. doi: 10.1186/s12872-021-01861-6.
4
Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians.南亚人、中国人和欧洲白种人中脂蛋白A(LPA)基因座的基因组变异及其与血浆脂蛋白(a)关系的综合分析。
Circ Cardiovasc Genet. 2010 Feb;3(1):39-46. doi: 10.1161/CIRCGENETICS.109.907642. Epub 2009 Dec 30.
5
Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study.载脂蛋白(a)和 LPA KIV2 重复多态性在二叶式主动脉瓣狭窄和钙化中的作用:概念验证研究。
Intern Emerg Med. 2019 Jan;14(1):45-50. doi: 10.1007/s11739-018-1925-8. Epub 2018 Aug 11.
6
Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease.常见的脂蛋白相关磷脂酶A2(LPA)KIV-2变异降低脂蛋白(a)浓度并预防冠状动脉疾病。
J Am Coll Cardiol. 2021 Aug 3;78(5):437-449. doi: 10.1016/j.jacc.2021.05.037.
7
Genetic variants associated with Lp(a) lipoprotein level and coronary disease.与脂蛋白(a)水平和冠心病相关的遗传变异。
N Engl J Med. 2009 Dec 24;361(26):2518-28. doi: 10.1056/NEJMoa0902604.
8
Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease.载脂蛋白(a)kringle IV重复序列数量可预测冠心病风险。
Arterioscler Thromb Vasc Biol. 1996 Jun;16(6):713-9. doi: 10.1161/01.atv.16.6.713.
9
LPA and PLG sequence variation and kringle IV-2 copy number in two populations.两个群体中LPA和PLG序列变异及kringle IV-2拷贝数
Hum Hered. 2008;66(4):199-209. doi: 10.1159/000143403. Epub 2008 Jul 9.
10
A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction.一种新型但常见的 LPA KIV-2 变异与明显的 Lp(a)降低和心血管风险降低有关。
Eur Heart J. 2017 Jun 14;38(23):1823-1831. doi: 10.1093/eurheartj/ehx174.

引用本文的文献

1
A novel deletion mutation in the LPA gene in a middle-aged woman with ischaemic stroke.一名中年缺血性脑卒中女性患者的 LPA 基因中存在一种新的缺失突变。
BMC Med Genomics. 2021 May 18;14(1):132. doi: 10.1186/s12920-021-00982-3.
2
Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study.中国社区普通人群中不同血脂谱下脂蛋白(a)升高与冠心病风险:CHCN-BTH研究
Ann Transl Med. 2021 Jan;9(1):26. doi: 10.21037/atm-20-3899.
3
The Association of SNPs Located in the CDKN2B-AS1 and LPA Genes With Carotid Artery Stenosis and Atherogenic Stroke.

本文引用的文献

1
LPA Gene, Ethnicity, and Cardiovascular Events.脂蛋白A基因、种族与心血管事件
Circulation. 2017 Jan 17;135(3):251-263. doi: 10.1161/CIRCULATIONAHA.116.024611. Epub 2016 Nov 9.
2
Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis-Brief Report.评估降低脂蛋白(a)对心肌梗死和主动脉瓣狭窄发病率的人群影响——简要报告
Arterioscler Thromb Vasc Biol. 2016 Dec;36(12):2421-2423. doi: 10.1161/ATVBAHA.116.308271. Epub 2016 Oct 20.
3
Lp(a) and cardiovascular risk: Investigating the hidden side of the moon.
位于CDKN2B-AS1和LPA基因的单核苷酸多态性与颈动脉狭窄和动脉粥样硬化性中风的关联
Front Neurol. 2019 Nov 22;10:1170. doi: 10.3389/fneur.2019.01170. eCollection 2019.
4
Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention.经皮冠状动脉介入治疗患者中脂蛋白(a)与主要不良心血管事件的关联
Arch Med Sci. 2019 Oct;15(6):1375-1380. doi: 10.5114/aoms.2018.79401. Epub 2018 Nov 6.
5
Elevated lipoprotein (a) levels are associated with the acute myocardial infarction in patients with normal low-density lipoprotein cholesterol levels.脂蛋白(a)水平升高与正常低密度脂蛋白胆固醇水平的急性心肌梗死患者有关。
Biosci Rep. 2019 Apr 5;39(4). doi: 10.1042/BSR20182096. Print 2019 Apr 30.
脂蛋白(a)与心血管风险:探索未知的一面。
Nutr Metab Cardiovasc Dis. 2016 Nov;26(11):980-986. doi: 10.1016/j.numecd.2016.07.004. Epub 2016 Jul 12.
4
Plasma lipoprotein(a) levels are associated with the severity of coronaryheart disease in Han Chinese people.血浆脂蛋白(a)水平与汉族人群冠心病严重程度相关。
Turk J Med Sci. 2016 Jun 23;46(4):1033-41. doi: 10.3906/sag-1502-74.
5
Is lipoprotein (a) protective of dementia?脂蛋白(a)对痴呆有保护作用吗?
Eur J Epidemiol. 2016 Nov;31(11):1149-1152. doi: 10.1007/s10654-016-0184-0. Epub 2016 Jul 13.
6
The relationship between Lp(a) and CVD outcomes: a systematic review.脂蛋白(a)与心血管疾病结局之间的关系:一项系统综述。
Lipids Health Dis. 2016 May 17;15:95. doi: 10.1186/s12944-016-0258-8.
7
Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future.孟德尔随机化法评估血脂对冠心病的因果效应:既往经验与未来应用
Curr Opin Endocrinol Diabetes Obes. 2016 Apr;23(2):124-30. doi: 10.1097/MED.0000000000000230.
8
Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism.载脂蛋白(a)kringle-IV型2拷贝数变异与静脉血栓栓塞相关。
PLoS One. 2016 Feb 22;11(2):e0149427. doi: 10.1371/journal.pone.0149427. eCollection 2016.
9
Future Directions to Establish Lipoprotein(a) as a Treatment for Atherosclerotic Cardiovascular Disease.将脂蛋白(a)确立为动脉粥样硬化性心血管疾病治疗方法的未来方向。
Cardiovasc Drugs Ther. 2016 Feb;30(1):101-8. doi: 10.1007/s10557-016-6654-5.
10
Lipoprotein(a): Revisiting a Next Therapeutic Target.脂蛋白(a):重新审视下一个治疗靶点。
Circ J. 2016;80(2):329-31. doi: 10.1253/circj.CJ-15-1381. Epub 2016 Jan 12.